Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma.
Saved in:
| Title: | Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma. |
|---|---|
| Authors: | Pazina T; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; FSBSI 'Institute of Experimental Medicine,' St. Petersburg, Russia., James AM; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Colby KB; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Yang Y; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Gale A; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Jhatakia A; Bristol-Myers Squibb, Princeton, New Jersey., Kearney AY; Bristol-Myers Squibb, Princeton, New Jersey., Graziano RF; Bristol-Myers Squibb, Princeton, New Jersey., Bezman NA; Bristol-Myers Squibb, Princeton, New Jersey., Robbins MD; Bristol-Myers Squibb, Princeton, New Jersey., Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. kerry.campbell@fccc.edu adam.cohen@uphs.upenn.edu., Campbell KS; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. kerry.campbell@fccc.edu adam.cohen@uphs.upenn.edu. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2019 Oct; Vol. 7 (10), pp. 1633-1646. Date of Electronic Publication: 2019 Aug 20. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
